Results 131 to 140 of about 3,676,382 (322)

Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients

Molecular Oncology, EarlyView.
Cancer‐associated fibroblasts (CAFs) promote cancer growth, invasion (metastasis), and drug resistance. Here, we identified functional and diverse circulating CAFs (cCAFs) in patients with metastatic prostate cancer (mPCa). cCAFs were found in higher numbers and were functional and diverse in mPCa patients versus healthy individuals, suggesting their ...
Richell Booijink, Leon W. M. M. Terstappen, Eshwari Dathathri, Khrystany Isebia, Jaco Kraan, John Martens, Ruchi Bansal   +6 more
wiley   +1 more source

Reliability of individual differences between garter snakes (Thamnophis radix) during repeated exposures to an open field [PDF]

, 1975
David Chiszar, Terrence Carter
openalex   +1 more source

Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells

Molecular Oncology, EarlyView.
In the era of immunotherapies, many patients either do not respond or eventually develop resistance. We propose to pave the way for proteomic analysis of surface‐expressed proteins called surfaceome, of circulating tumor cells. This approach seeks to identify immune evasion mechanisms and discover potential therapeutic targets. Circulating tumor cells (
Doryan Masmoudi, Jérome Vialaret, Christophe Hirtz, Catherine Alix‐Panabières   +3 more
wiley   +1 more source

The Determination of Fat in the Presence of Free Fatty Acids. II. Differences in the Behavior of Individual Acids in the Mojoinnier Test

, 1941
Mortimer P. Starr, B.L. Herrington
openalex   +1 more source

Individual differences and associational strategies within whole-list, mastery paired-associate learning [PDF]

, 1978
William M. Timpson, Robert E. Davidson, Frank H. Farley   +2 more
openalex   +1 more source

Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

Molecular Oncology, EarlyView.
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, Simon P. Gampenrieder, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Michael Hubalek, Katja Schmitz, Zsuzsanna Bago‐Horvath, Andreas Petzer, Sonja Heibl, Ellen Heitzer, Marija Balic, Michael Gnant   +14 more
wiley   +1 more source

Self-deception Beyond Speculation: A Narrative Review of the Empirical Research on Motivated False Beliefs

Studia Universitatis Babeş-Bolyai. Psychologia-Paedagogia
This narrative review explores the concept of self-deception, departing from its theoretical foundations in philosophy and psychology, and focusing on the pioneering empirical methods used to study it.
Mara Georgiana MOLDOVEANU, Laura VISU-PETRA   +1 more
doaj   +1 more source

Beyond Average: Individualized Visual Scanpath Prediction [PDF]

arXiv
Understanding how attention varies across individuals has significant scientific and societal impacts. However, existing visual scanpath models treat attention uniformly, neglecting individual differences. To bridge this gap, this paper focuses on individualized scanpath prediction (ISP), a new attention modeling task that aims to accurately predict ...
arxiv  

Individual differences and interrelationships among a select set of cognitive skills [PDF]

, 1976
Alice Chiang, Richard C. Atkinson
openalex   +1 more source

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

Molecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Elin Borgen, Cecilie Bendigtsen Schirmer, Bjørnar Gilje, Øystein Garred, Jon Lømo, Marius Stensland, Oddmund Nordgård, Ragnhild Sørum Falk, Randi R. Mathiesen, Hege G. Russnes, Jon Amund Kyte, Bjørn Naume   +13 more
wiley   +1 more source